Cargando…

Radiotherapy/Chemotherapy-Immunotherapy for Cancer Management: From Mechanisms to Clinical Implications

Cancer immunotherapy has drawn much attention because it can restart the recognition and killing function of the immune system to normalize the antitumor immune response. However, the role of radiotherapy and chemotherapy in cancer treatment cannot be ignored. Due to cancer heterogeneity, combined t...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qian, Lei, Xu, Zhu, Jing, Zhong, Yanping, Yang, Junjie, Wang, Jincheng, Tan, Huabing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911251/
https://www.ncbi.nlm.nih.gov/pubmed/36778203
http://dx.doi.org/10.1155/2023/7530794
_version_ 1784884953533644800
author Li, Qian
Lei, Xu
Zhu, Jing
Zhong, Yanping
Yang, Junjie
Wang, Jincheng
Tan, Huabing
author_facet Li, Qian
Lei, Xu
Zhu, Jing
Zhong, Yanping
Yang, Junjie
Wang, Jincheng
Tan, Huabing
author_sort Li, Qian
collection PubMed
description Cancer immunotherapy has drawn much attention because it can restart the recognition and killing function of the immune system to normalize the antitumor immune response. However, the role of radiotherapy and chemotherapy in cancer treatment cannot be ignored. Due to cancer heterogeneity, combined therapy has become a new trend, and its efficacy has been confirmed in many studies. This review discussed the clinical implications and the underlying mechanisms of cancer immunotherapy in combination with radiotherapy or chemotherapy, offering an outline for clinicians as well as inspiration for future research.
format Online
Article
Text
id pubmed-9911251
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-99112512023-02-10 Radiotherapy/Chemotherapy-Immunotherapy for Cancer Management: From Mechanisms to Clinical Implications Li, Qian Lei, Xu Zhu, Jing Zhong, Yanping Yang, Junjie Wang, Jincheng Tan, Huabing Oxid Med Cell Longev Review Article Cancer immunotherapy has drawn much attention because it can restart the recognition and killing function of the immune system to normalize the antitumor immune response. However, the role of radiotherapy and chemotherapy in cancer treatment cannot be ignored. Due to cancer heterogeneity, combined therapy has become a new trend, and its efficacy has been confirmed in many studies. This review discussed the clinical implications and the underlying mechanisms of cancer immunotherapy in combination with radiotherapy or chemotherapy, offering an outline for clinicians as well as inspiration for future research. Hindawi 2023-02-02 /pmc/articles/PMC9911251/ /pubmed/36778203 http://dx.doi.org/10.1155/2023/7530794 Text en Copyright © 2023 Qian Li et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Li, Qian
Lei, Xu
Zhu, Jing
Zhong, Yanping
Yang, Junjie
Wang, Jincheng
Tan, Huabing
Radiotherapy/Chemotherapy-Immunotherapy for Cancer Management: From Mechanisms to Clinical Implications
title Radiotherapy/Chemotherapy-Immunotherapy for Cancer Management: From Mechanisms to Clinical Implications
title_full Radiotherapy/Chemotherapy-Immunotherapy for Cancer Management: From Mechanisms to Clinical Implications
title_fullStr Radiotherapy/Chemotherapy-Immunotherapy for Cancer Management: From Mechanisms to Clinical Implications
title_full_unstemmed Radiotherapy/Chemotherapy-Immunotherapy for Cancer Management: From Mechanisms to Clinical Implications
title_short Radiotherapy/Chemotherapy-Immunotherapy for Cancer Management: From Mechanisms to Clinical Implications
title_sort radiotherapy/chemotherapy-immunotherapy for cancer management: from mechanisms to clinical implications
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911251/
https://www.ncbi.nlm.nih.gov/pubmed/36778203
http://dx.doi.org/10.1155/2023/7530794
work_keys_str_mv AT liqian radiotherapychemotherapyimmunotherapyforcancermanagementfrommechanismstoclinicalimplications
AT leixu radiotherapychemotherapyimmunotherapyforcancermanagementfrommechanismstoclinicalimplications
AT zhujing radiotherapychemotherapyimmunotherapyforcancermanagementfrommechanismstoclinicalimplications
AT zhongyanping radiotherapychemotherapyimmunotherapyforcancermanagementfrommechanismstoclinicalimplications
AT yangjunjie radiotherapychemotherapyimmunotherapyforcancermanagementfrommechanismstoclinicalimplications
AT wangjincheng radiotherapychemotherapyimmunotherapyforcancermanagementfrommechanismstoclinicalimplications
AT tanhuabing radiotherapychemotherapyimmunotherapyforcancermanagementfrommechanismstoclinicalimplications